Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ecker

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Farmaco (Societa Chimica Italiana : 1989)|February 12, 2004
Development of an in vitro blood-brain barrier model based on immortalized porcine brain microvascular endothelial cellsRegina Lauer, Roland Bauer, Birgit Linz, et al.
Molecules (Basel, Switzerland)|January 23, 2015
Synthesis and in silico evaluation of novel compounds for PET-based investigations of the norepinephrine transporterCatharina Neudorfer, Amir Seddik, Karem Shanab, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2014
Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's diseaseCatharina Neudorfer, Karem Shanab, Andreas Jurik, et al.
Drug Discovery Today|June 12, 2012
Open PHACTS: semantic interoperability for drug discoveryAntony J Williams, Lee Harland, Paul Groth, et al.
Chemico-Biological Interactions|October 31, 2021
The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compoundsTim Brecklinghaus, Wiebke Albrecht, Franziska Kappenberg, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
Nature Reviews. Drug Discovery|April 9, 2020
The RESOLUTE consortium: unlocking SLC transporters for drug discoveryGiulio Superti-Furga, Daniel Lackner, Tabea Wiedmer, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Farmaco (Societa Chimica Italiana : 1989)|February 12, 2004
Development of an in vitro blood-brain barrier model based on immortalized porcine brain microvascular endothelial cellsRegina Lauer, Roland Bauer, Birgit Linz, et al.
Molecules (Basel, Switzerland)|January 23, 2015
Synthesis and in silico evaluation of novel compounds for PET-based investigations of the norepinephrine transporterCatharina Neudorfer, Amir Seddik, Karem Shanab, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2014
Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's diseaseCatharina Neudorfer, Karem Shanab, Andreas Jurik, et al.
Drug Discovery Today|June 12, 2012
Open PHACTS: semantic interoperability for drug discoveryAntony J Williams, Lee Harland, Paul Groth, et al.
Chemico-Biological Interactions|October 31, 2021
The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compoundsTim Brecklinghaus, Wiebke Albrecht, Franziska Kappenberg, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
Nature Reviews. Drug Discovery|April 9, 2020
The RESOLUTE consortium: unlocking SLC transporters for drug discoveryGiulio Superti-Furga, Daniel Lackner, Tabea Wiedmer, et al.
Pageof 2